Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Shah Nimesh — Neothetics, Inc. insider · InsiderLens

Home / Insiders / Shah Nimesh

Shah Nimesh

10% owner at Neothetics, Inc. · on record since Dec 18, 2015
10% owner at MARINUS PHARMACEUTICALS INC · on record since Dec 18, 2015
10% owner at Regado Biosciences Inc · on record since Dec 18, 2015
10% owner at Aldeyra Therapeutics, Inc. · on record since Dec 18, 2015
10% owner at Evoke Pharma Inc · on record since Dec 18, 2015
10% owner at TRANZYME INC · on record since Dec 18, 2015
10% owner at Esperion Therapeutics, Inc. · on record since Dec 18, 2015
10% owner at Syndax Pharmaceuticals Inc · on record since Mar 2, 2016

Insider trading activity of Shah Nimesh

No transactions on record for Shah Nimesh.

Track record of Shah Nimesh

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Shah Nimesh

Co-insiders of Shah Nimesh

BLAIR JAMES CAldeyra Therapeutics, Inc. +7
DOMAIN ASSOCIATESAldeyra Therapeutics, Inc. +7
DOVEY BRIAN HAldeyra Therapeutics, Inc. +7
Halak Brian KAldeyra Therapeutics, Inc. +7
Kamdar Kim P.Aldeyra Therapeutics, Inc. +7
TREU JESSE IAldeyra Therapeutics, Inc. +7
VITULLO NICOLEAldeyra Therapeutics, Inc. +7

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

SCHOEMAKER KATHLEEN KAldeyra Therapeutics, Inc. +6

Domain Partners VI, L.P.Aldeyra Therapeutics, Inc. +4

DP VI Associates, L.P.Aldeyra Therapeutics, Inc. +4

DOMAIN PARTERS VII L PEsperion Therapeutics, Inc. +3

DP VII ASSOCIATES LPEsperion Therapeutics, Inc. +3

Alta Partners Management VIII, LLCEsperion Therapeutics, Inc. +1

Alta Partners VIII, L.P.Esperion Therapeutics, Inc. +1

Azan AlainMARINUS PHARMACEUTICALS INC +1

BIOTECHNOLOGY VALUE FUND II LPRegado Biosciences Inc +1

BIOTECHNOLOGY VALUE FUND L PRegado Biosciences Inc +1

Brady Todd CAldeyra Therapeutics, Inc. +1

Braunstein ScottEsperion Therapeutics, Inc. +1

Buatois EricMARINUS PHARMACEUTICALS INC +1

BVF INC/ILRegado Biosciences Inc +1

BVF PARTNERS L P/ILRegado Biosciences Inc +1

CHAMPSI FARAHEsperion Therapeutics, Inc. +1

Domain Partners VIII, L.P.Syndax Pharmaceuticals Inc +1

DP VIII Associates, L.P.Syndax Pharmaceuticals Inc +1

Fischer Seth H.Z.Esperion Therapeutics, Inc. +1

Gopka AntonMARINUS PHARMACEUTICALS INC +1

HEALY JAMESMARINUS PHARMACEUTICALS INC +1

JANNEY DANIELEsperion Therapeutics, Inc. +1

LAMPERT MARK NRegado Biosciences Inc +1

Legault PierreRegado Biosciences Inc +1

MAYLEBEN TIMOTHY MEsperion Therapeutics, Inc. +1

Metzger Michael ARegado Biosciences Inc +1

NOHRA GUY PEsperion Therapeutics, Inc. +1

Podlesak DennisRegado Biosciences Inc +1

POWELL MICHAELMARINUS PHARMACEUTICALS INC +1

QUAKER BIOVENTURES CAPITAL LPRegado Biosciences Inc +1

QUAKER BIO VENTURES LPRegado Biosciences Inc +1

RMI Investments S.a.r.l.Neothetics, Inc. +1

RusnanoMedInvest LLCNeothetics, Inc. +1

Shepard JayEsperion Therapeutics, Inc. +1

Sofinnova Management VI, L.L.C.MARINUS PHARMACEUTICALS INC +1

Sofinnova Venture Affiliates VI LPMARINUS PHARMACEUTICALS INC +1

Sofinnova Venture Partners VI GmbH & Co. KGMARINUS PHARMACEUTICALS INC +1

SOFINNOVA VENTURE PARTNERS VI L PMARINUS PHARMACEUTICALS INC +1

WEBER ECKARDRegado Biosciences Inc +1

14159 capital (GP), LLCTRANZYME INC

ABERCROMBIE GEORGE BTRANZYME INC

ACACIA RESEARCH CORPNeothetics, Inc.

Actavis plcRegado Biosciences Inc

No transactions on record. Reset filters